Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal Cancer

被引:0
|
作者
Conces, Madison L. [1 ]
Mahipal, Amit [1 ]
机构
[1] Case Western Reserve Univ, Univ Hosp Seidman Canc Ctr, Cleveland, OH 44106 USA
关键词
rectal cancer; neoadjuvant therapy; chemotherapy; TOTAL MESORECTAL EXCISION; POSTOPERATIVE ADJUVANT CHEMOTHERAPY; COURSE PREOPERATIVE RADIOTHERAPY; CLINICAL COMPLETE RESPONDERS; MEDIAN FOLLOW-UP; QUALITY-OF-LIFE; INTERNATIONAL WATCH; SEXUAL DYSFUNCTION; COLORECTAL-CANCER; RANDOMIZED-TRIAL;
D O I
10.3390/curroncol31010024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Local and metastatic recurrence are primary concerns following the treatment of locally advanced rectal cancer (LARC). Chemoradiation (CRT) can reduce the local recurrence rates and has subsequently moved to the neoadjuvant setting from the adjuvant setting. Pathological complete response (pCR) rates have also been noted to be greater in patients treated with neoadjuvant CRT prior to surgery. The standard approach to treating LARC would often involve CRT followed by surgery and optional adjuvant chemotherapy and remained the treatment paradigm for almost two decades. However, patients were often unable to complete adjuvant chemotherapy due to a decreased tolerance of chemotherapy following surgery, which led to upfront treatment with both CRT and chemotherapy, and total neoadjuvant therapy, or TNT, was created. The efficacy outcomes of local recurrence, disease-free survival, and pCR have improved in patients receiving TNT compared to the standard approach. Additionally, more recent data suggest a possible improvement in overall survival as well. Patients with a complete clinical response following TNT have the opportunity for watch-and-wait surveillance, allowing some patients to undergo organ preservation. Here, we discuss the clinical trials and studies that led to the adoption of TNT as the standard of care for LARC, with the possibility of watch-and-wait surveillance for patients achieving complete responses. We also review the possibility of overtreating some patients with LARC.
引用
收藏
页码:366 / 382
页数:17
相关论文
共 50 条
  • [1] Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
    Cercek, Andrea
    Roxburgh, Campbell S. D.
    Strombom, Paul
    Smith, J. Joshua
    Temple, Larissa K. F.
    Nash, Garrett M.
    Guillem, Jose G.
    Paty, Philip B.
    Yaeger, Rona
    Stadler, Zsofia K.
    Seier, Kenneth
    Gonen, Mithat
    Segal, Neil H.
    Reidy, Diane L.
    Varghese, Anna
    Shia, Jinru
    Vakiani, Efsevia
    Wu, Abraham J.
    Crane, Christopher H.
    Gollub, Marc J.
    Garcia-Aguilar, Julio
    Saltz, Leonard B.
    Weiser, Martin R.
    JAMA ONCOLOGY, 2018, 4 (06)
  • [2] Trends in the Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
    Mesiti, Andrea M.
    Herre, Margaret
    Qiu, Yuqing
    Jafari, Mehraneh D.
    Pigazzi, Alessio
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S63 - S64
  • [3] Trends in adoption of total neoadjuvant therapy for locally advanced rectal cancer
    Unuvar, Maria
    Blansfield, Joseph
    Wang, Shengxuan
    Hoffman, Rebecca L.
    AMERICAN JOURNAL OF SURGERY, 2024, 227 : 229 - 236
  • [4] Total neoadjuvant therapy for locally advanced rectal cancer
    Cercek, Andrea
    Roxburgh, Campbell S. D.
    Strombom, Paul
    Smith, Jesse Joshua
    Temple, Larissa K. F.
    Nash, Garrett Michael
    Guillem, Jose G.
    Paty, Philip
    Garcia-Aguilar, Julio
    Yaeger, Rona D.
    Stadler, Zsofia Kinga
    Segal, Neil Howard
    Reidy, Diane Lauren
    Shia, Jinru
    Vakiani, Efsevia
    Wu, Abraham Jing-Ching
    Crane, Christopher H.
    Gollub, Marc Jeffrey
    Saltz, Leonard
    Weiser, Martin R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Total neoadjuvant treatment in locally advanced rectal cancer
    De Felice, Francesca
    Tombolini, Vincenzo
    Cortesi, Enrico
    TRANSLATIONAL ONCOLOGY, 2021, 14 (05):
  • [6] Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
    Guida, Andrea M.
    Sensi, Bruno
    Formica, Vincenzo
    D'Angelillo, Rolando M.
    Roselli, Mario
    Blanco, Giovanna Del Vecchio
    Rossi, Piero
    Capolupo, Gabriella T.
    Caricato, Marco
    Sica, Giuseppe S.
    BIOLOGY DIRECT, 2022, 17 (01)
  • [7] Total neoadjuvant therapy for locally advanced rectal cancer A meaningful treatment option?
    Lauscher, Johannes
    Stintzing, Sebastian
    Boehmer, Dirk
    COLOPROCTOLOGY, 2022, 44 (04) : 221 - 228
  • [8] Total neoadjuvant therapy for the treatment of locally advanced rectal cancer: a systematic minireview
    Andrea M. Guida
    Bruno Sensi
    Vincenzo Formica
    Rolando M. D’Angelillo
    Mario Roselli
    Giovanna Del Vecchio Blanco
    Piero Rossi
    Gabriella T. Capolupo
    Marco Caricato
    Giuseppe S. Sica
    Biology Direct, 17
  • [9] Total neoadjuvant therapy for each locally advanced rectal cancer?
    Gudrun Piringer
    memo - Magazine of European Medical Oncology, 2024, 17 : 15 - 19
  • [10] Locally Advanced Rectal Cancer: New Neoadjuvant Strategies and Total Neoadjuvant Therapy
    Hofheinz, Ralf-Dieter
    ZENTRALBLATT FUR CHIRURGIE, 2024, 149 (01): : 56 - 66